Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
ELUT
Elutia Inc.
CAPPED RATING
Elutia Inc. (ELUT) is rated C+ (2.6/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (A-); its weakest is Growth (F).
Quantitative Factor Evaluation • Updated
Overall Rating
2.6
/ 5.0
C+
Value
B-
Factor Score
3.0
/ 5.0
Growth
F
Factor Score
0.6
/ 5.0
Profitability
A-
Factor Score
3.9
/ 5.0
Momentum
C+
Factor Score
2.8
/ 5.0
Revisions
C+
Factor Score
2.6
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
-0.8
EV / EBITDA
-0.9
Rev Growth YoY
-65.8%
Gross Margin
57.7%
Price Return 3M
14.1%
Price Return 12M
4.3%
Catalyst Signal
0.00
Market Cap
$41.3M
TTM Revenue
$13.6M
Price / Sales
3.0
ROE
N/A
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-11 | B- (3.0) | F (0.6) | A- (3.9) | C+ (2.8) | C+ (2.6) | C+ (2.6) |
| 2026-11-04 | B- (3.0) | D (1.2) | B (3.3) | C+ (2.6) | C+ (2.7) | C+ (2.5) |
| 2026-10-28 | B- (3.0) | D (1.2) | B (3.3) | C (2.3) | C+ (2.7) | C (2.5) |
| 2026-10-21 | B- (3.0) | D (1.2) | B (3.3) | C- (2.1) | C+ (2.6) | C (2.4) |
| 2026-10-14 | B- (3.0) | D- (1.1) | B (3.3) | C- (1.9) | C+ (2.6) | C (2.4) |
Page
1
of
4